MA is able to inhibit the activation of γδT17 cells through PPARγ–PTEN/Akt/GSK3β/NFAT pathway, reduce the level of IL-17 in colon tissues of colitis mice, and ameliorate DSS-induced colitis in mice. This evidence concerns the gene PTEN and colitis.